Sign In

Login

Password

Forgot Password ? Sign Up

UB-612 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "UB-612" in French language version.

refsWebsite
Global rank French rank
6nih.gov
4th place
12th place
5doi.org
2nd place
3rd place
4clinicaltrials.gov
5,225th place
6,624th place
1taiwannews.com.tw
3,205th place
4,902nd place
1vaxxinity.com
low place
low place
1web.archive.org
1st place
1st place
1issn.org
57th place
4th place
1bizjournals.com
407th place
1,685th place
1contagionlive.com
low place
low place
1dimensions.ai
low place
low place

bizjournals.com

clinicaltrials.gov

  • (en) Essai clinique NCT04545749 intitulé « A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine » sur ClinicalTrials.gov.
  • (en) Essai clinique NCT04683224 intitulé « A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine » sur ClinicalTrials.gov.
  • (en) Essai clinique NCT04773067 intitulé « A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers » sur ClinicalTrials.gov.
  • (en) Essai clinique NCT05293665 intitulé « Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine » sur ClinicalTrials.gov.

contagionlive.com

dimensions.ai

app.dimensions.ai

  • « Targeting Multiple Conserved T-Cell Epitopes for Protection against COVID-19 Moderate-Severe Disease by a Pan-Sarbecovirus Vaccine », medRxiv,‎ (lire en ligne)

doi.org

dx.doi.org

  • « SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants », Frontiers in Immunology, vol. 12,‎ , p. 701501 (PMID 34322129, PMCID 8311925, DOI 10.3389/fimmu.2021.701501)
  • Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo et Wen-Jiun Peng, « A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants », The Journal of Clinical Investigation, vol. 132, no 10,‎ , e157707 (ISSN 1558-8238, PMID 35316221, PMCID 9106357, DOI 10.1172/JCI157707, lire en ligne, consulté le )
  • « High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster », The Journal of Infectious Diseases, vol. 226, no 8,‎ , p. 1401–1406 (PMID 35723969, PMCID 9278180, DOI 10.1093/infdis/jiac241)
  • « Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses », PLOS Pathogens, vol. 19, no 4,‎ , e1010870 (PMID 37079651, PMCID 10153712, DOI 10.1371/journal.ppat.1010870)
  • « UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease », iScience, vol. 27, no 2,‎ , p. 108887 (PMID 38318376, PMCID 10839960, DOI 10.1016/j.isci.2024.108887)

issn.org

portal.issn.org

  • Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo et Wen-Jiun Peng, « A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants », The Journal of Clinical Investigation, vol. 132, no 10,‎ , e157707 (ISSN 1558-8238, PMID 35316221, PMCID 9106357, DOI 10.1172/JCI157707, lire en ligne, consulté le )

nih.gov

ncbi.nlm.nih.gov

  • « SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants », Frontiers in Immunology, vol. 12,‎ , p. 701501 (PMID 34322129, PMCID 8311925, DOI 10.3389/fimmu.2021.701501)
  • Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo et Wen-Jiun Peng, « A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants », The Journal of Clinical Investigation, vol. 132, no 10,‎ , e157707 (ISSN 1558-8238, PMID 35316221, PMCID 9106357, DOI 10.1172/JCI157707, lire en ligne, consulté le )
  • « High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster », The Journal of Infectious Diseases, vol. 226, no 8,‎ , p. 1401–1406 (PMID 35723969, PMCID 9278180, DOI 10.1093/infdis/jiac241)
  • « Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses », PLOS Pathogens, vol. 19, no 4,‎ , e1010870 (PMID 37079651, PMCID 10153712, DOI 10.1371/journal.ppat.1010870)
  • « UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease », iScience, vol. 27, no 2,‎ , p. 108887 (PMID 38318376, PMCID 10839960, DOI 10.1016/j.isci.2024.108887)

pubmed.ncbi.nlm.nih.gov

  • Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo et Wen-Jiun Peng, « A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants », The Journal of Clinical Investigation, vol. 132, no 10,‎ , e157707 (ISSN 1558-8238, PMID 35316221, PMCID 9106357, DOI 10.1172/JCI157707, lire en ligne, consulté le )

taiwannews.com.tw

vaxxinity.com

web.archive.org